These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 3508655)

  • 61. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.
    Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Clin Immunol; 2005 May; 115(2):154-61. PubMed ID: 15885638
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Studies on live rubella vaccine. V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine.
    Minekawa Y; Ueda S; Yamanishi K; Ogino T; Takahashi M
    Biken J; 1974 Dec; 17(4):161-7. PubMed ID: 4464833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine.
    Berger R; Just M; Glück R
    J Biol Stand; 1988 Oct; 16(4):269-73. PubMed ID: 3198657
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immune response and vaccine efficiency.
    Schlegel M; Vernazza PL
    Vaccine; 1998 Aug; 16(13):1256. PubMed ID: 9682387
    [No Abstract]   [Full Text] [Related]  

  • 65. [Vaccine coverage and levels of protection with triple viral vaccine in a children population].
    Sánchez Serrano LP; Corcuera MT; Molina MP; de Miguel C; Lozano J; Oñorbe JA; Barberá G
    Enferm Infecc Microbiol Clin; 1990; 8(6):384-7. PubMed ID: 2081176
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. Should we be concerned?
    Watada B; Kennedy K; Chan D; Church B; Patriquin M; Shariff F; Evans MF
    Can Fam Physician; 1998 Jan; 44():53-5. PubMed ID: 9481462
    [No Abstract]   [Full Text] [Related]  

  • 68. Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine.
    Berger R; Just M
    J Biol Stand; 1988 Oct; 16(4):275-9. PubMed ID: 2848843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immune response and vaccine efficacy.
    Afzal MA; Minor PD
    Vaccine; 1999 Apr; 17(15-16):1813. PubMed ID: 10217577
    [No Abstract]   [Full Text] [Related]  

  • 71. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection.
    Frenkel LM; Nielsen K; Garakian A; Cherry JD
    Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Preventive vaccination (DPT, HiB, polio, MMR) in hepatitis B virus carrier status?].
    Wiersbitzky S
    Kinderarztl Prax; 1993 Dec; 61(10):376-7. PubMed ID: 8145455
    [No Abstract]   [Full Text] [Related]  

  • 73. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
    Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antibody response to measles and rubella vaccine by children with HIV infection.
    Breña AE; Cooper ER; Cabral HJ; Pelton SI
    J Acquir Immune Defic Syndr (1988); 1993 Oct; 6(10):1125-9. PubMed ID: 8410669
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serological evaluation of a measles, mumps, and rubella vaccine.
    Robertson CM; Bennett VJ; Jefferson N; Mayon-White RT
    Arch Dis Child; 1988 Jun; 63(6):612-6. PubMed ID: 3291787
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
    Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
    Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
    Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
    Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Increased risk of invasive bacterial infections after preventive mumps-measles-rubella vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Jun; 61(4-5):170-1. PubMed ID: 8361148
    [No Abstract]   [Full Text] [Related]  

  • 80. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.